Archives of Clinical Infectious Diseases

Published by: Kowsar

Antibiotic Resistance Among Helicobacter pylori Strains Isolated from Patients with Histopathological Changes of the Gastric Tissue Towards Metronidazole, Clarithromycin, and Ciprofloxacin

Saeed Bayati 1 , Nour Amirmozafari 1 , * , Masoud Alebouyeh 2 , 3 , ** , Nastaran Farzi 2 , Nasser Ebrahimi Daryani 4 and Mohammad Reza Zali 5
Authors Information
1 Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2 Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Pediatric Infections Research Center (PIRC), Research Institute for Children Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Department of Gastroenterology and Hepatology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
5 Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Science, Tehran, Iran
Corresponding Authors:
Article information
  • Archives of Clinical Infectious Diseases: February 28, 2019, 14 (1); e55015
  • Published Online: February 26, 2019
  • Article Type: Research Article
  • Received: June 14, 2017
  • Revised: October 9, 2018
  • Accepted: October 28, 2018
  • DOI: 10.5812/archcid.55015

To Cite: Bayati S, Amirmozafari N, Alebouyeh M, Farzi N, Ebrahimi Daryani N, et al. Antibiotic Resistance Among Helicobacter pylori Strains Isolated from Patients with Histopathological Changes of the Gastric Tissue Towards Metronidazole, Clarithromycin, and Ciprofloxacin, Arch Clin Infect Dis. 2019 ; 14(1):e55015. doi: 10.5812/archcid.55015.

Abstract
Copyright © 2019, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev. 1997;10(4):720-41. [PubMed: 9336670]. [PubMed Central: PMC172942].
  • 2. Feldman M, Friedman LS, Brandt LJ. Sleisenger and fortran's. Gastrointestinal and liver disease. 8th ed. Philadelphia: Saunders; 2006.
  • 3. Lacy BE, Rosemore J. Helicobacter pylori: ulcers and more: The beginning of an era. J Nutr. 2001;131(10):2789S-93S. doi: 10.1093/jn/131.10.2789S. [PubMed: 11584108].
  • 4. Gisbert JP, Calvet X, O'Connor A, Megraud F, O'Morain CA. Sequential therapy for Helicobacter pylori eradication: A critical review. J Clin Gastroenterol. 2010;44(5):313-25. doi: 10.1097/MCG.0b013e3181c8a1a3. [PubMed: 20054285].
  • 5. Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102(8):1808-25. doi: 10.1111/j.1572-0241.2007.01393.x. [PubMed: 17608775].
  • 6. Kaboli SA, Zojaji H, Mirsattari D, Talaie R, Derakhshan F, Zali MR, et al. Effect of addition of vitamin C to clarithromycin-amoxicillin-omeprazol triple regimen on Helicobacter pylori eradication. Acta Gastroenterol Belg. 2009;72(2):222-4. [PubMed: 19637777].
  • 7. Zojaji H, Talaie R, Mirsattari D, Haghazali M, Molaei M, Mohsenian N, et al. The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation. Dig Liver Dis. 2009;41(9):644-7. doi: 10.1016/j.dld.2008.09.008. [PubMed: 19493713].
  • 8. Saberi-Firoozi M, Nejabat M. Experiences with helicobacter pylori treatment in Iran. Iran J Med Sci. 2006;31(4):181-5.
  • 9. Khademi F, Poursina F, Hosseini E, Akbari M, Safaei HG. Helicobacter pylori in Iran: A systematic review on the antibiotic resistance. Iran J Basic Med Sci. 2015;18(1):2-7. [PubMed: 25810869]. [PubMed Central: PMC4366738].
  • 10. Shokrzadeh L, Alebouyeh M, Mirzaei T, Farzi N, Zali MR. Prevalence of multiple drug-resistant Helicobacter pylori strains among patients with different gastric disorders in Iran. Microb Drug Resist. 2015;21(1):105-10. doi: 10.1089/mdr.2014.0081. [PubMed: 25303151].
  • 11. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Seventeenth informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
  • 12. EUCAST. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters, Version 2.0, valid from 2012-01-01. 2012.
  • 13. Wolle K, Nilius M, Leodolter A, Muller WA, Malfertheiner P, Konig W. Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany. Eur J Clin Microbiol Infect Dis. 1998;17(7):519-21. [PubMed: 9764558].
  • 14. Chang WL, Sheu BS, Cheng HC, Yang YJ, Yang HB, Wu JJ. Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan. J Gastroenterol Hepatol. 2009;24(7):1230-5. doi: 10.1111/j.1440-1746.2009.05829.x. [PubMed: 19476562].
  • 15. Ching CK, Leung KP, Yung RW, Lam SK, Wong BC, Lai KC, et al. Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. Gut. 1996;38(5):675-8. [PubMed: 8707111]. [PubMed Central: PMC1383147].
  • 16. Olokoba AB, Obateru OA, Bojuwoye MO. Helicobacter pylori eradication therapy: A review of current trends. Niger Med J. 2013;54(1):1-4. doi: 10.4103/0300-1652.108884. [PubMed: 23661891]. [PubMed Central: PMC3644737].
  • 17. Navidifar T, Eslami G, Akhondi M, Baghbanian M, Fallah Zadeh H, Zandi H. Antibacterial resistance patterns of helicobacter pylori clinical isolates from gastric biopsy of patients in Yazd. Int J Enteric Pathog. 2014;2(2). doi: 10.17795/ijep17791.
  • 18. De Francesco V, Giorgio F, Hassan C, Manes G, Vannella L, Panella C, et al. Worldwide H. pylori antibiotic resistance: A systematic review. J Gastrointestin Liver Dis. 2010;19(4):409-14. [PubMed: 21188333].
  • 19. Pilotto A, Rassu M, Leandro G, Franceschi M, Di Mario F, Interdisciplinary Group for the Study of U. Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: A multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer. Dig Liver Dis. 2000;32(9):763-8. [PubMed: 11215555].
  • 20. Saracino IM, Zullo A, Holton J, Castelli V, Fiorini G, Zaccaro C, et al. High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy. J Gastrointestin Liver Dis. 2012;21(4):363-5. [PubMed: 23256118].
  • 21. Gehlot V, Mahant S, Mukhopadhyay AK, Das K, De R, Kar P, et al. Antimicrobial susceptibility profiles of Helicobacter pylori isolated from patients in North India. J Glob Antimicrob Resist. 2016;5:51-6. doi: 10.1016/j.jgar.2015.09.009. [PubMed: 27436467].
  • 22. Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62(1):34-42. doi: 10.1136/gutjnl-2012-302254. [PubMed: 22580412].
  • 23. An B, Moon BS, Kim H, Lim HC, Lee YC, Lee G, et al. Antibiotic resistance in Helicobacter pylori strains and its effect on H. pylori eradication rates in a single center in Korea. Ann Lab Med. 2013;33(6):415-9. doi: 10.3343/alm.2013.33.6.415. [PubMed: 24205490]. [PubMed Central: PMC3819440].
  • 24. Khademi F, Faghri J, Poursina F, Esfahani BN, Moghim S, Fazeli H, et al. Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran. J Res Med Sci. 2013;18(12):1056-60. [PubMed: 24523796]. [PubMed Central: PMC3908526].
  • 25. Keshavarz Azizi Raftar S, Moniri R, Saffari M, Razavi Zadeh M, Arj A, Mousavi SG, et al. The Helicobacter pylori resistance rate to clarithromycin in Iran. Microb Drug Resist. 2015;21(1):69-73. doi: 10.1089/mdr.2014.0104. [PubMed: 25144338].
  • 26. Aftab H, Miftahussurur M, Subsomwong P, Ahmed F, Khan AK, Yamaoka Y. Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance. J Infect Dev Ctries. 2016;10(3):245-53. doi: 10.3855/jidc.7713. [PubMed: 27031456].
  • 27. Ji Z, Han F, Meng F, Tu M, Yang N, Zhang J. The association of age and antibiotic resistance of helicobacter pylori: A study in Jiaxing City, Zhejiang province, China. Medicine (Baltimore). 2016;95(8). e2831. doi: 10.1097/MD.0000000000002831. [PubMed: 26937912]. [PubMed Central: PMC4779009].
  • 28. Bai P, Zhou LY, Xiao XM, Luo Y, Ding Y. Susceptibility of Helicobacter pylori to antibiotics in Chinese patients. J Dig Dis. 2015;16(8):464-70. doi: 10.1111/1751-2980.12271. [PubMed: 26147515].
  • 29. Ghotaslou R, Leylabadlo HE, Asl YM. Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review. World J Methodol. 2015;5(3):164-74. doi: 10.5662/wjm.v5.i3.164. [PubMed: 26413490]. [PubMed Central: PMC4572030].
  • 30. Llanes R, Soria C, Nagashima S, Kobayashi N, Gala A, Guzman D, et al. Phenotypic and genetic characterization of antimicrobial profiles of Helicobacter pylori strains in Cuba. J Health Popul Nutr. 2010;28(2):124-9. [PubMed: 20411674]. [PubMed Central: PMC2980873].
  • 31. Shokrzadeh L, Jafari F, Dabiri H, Baghaei K, Zojaji H, Alizadeh AH, et al. Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, Iran. Saudi J Gastroenterol. 2011;17(4):261-4. doi: 10.4103/1319-3767.82581. [PubMed: 21727733]. [PubMed Central: PMC3133984].
  • 32. Boyanova L, Ilieva J, Gergova G, Davidkov L, Spassova Z, Kamburov V, et al. Numerous risk factors for Helicobacter pylori antibiotic resistance revealed by extended anamnesis: A Bulgarian study. J Med Microbiol. 2012;61(Pt 1):85-93. doi: 10.1099/jmm.0.035568-0. [PubMed: 21873378].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments